Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperparathyroidism, Secondary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT03633708
What this trial is testing

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 56
Post-approval studies (Phase 4)Study completedNCT00891813
What this trial is testing

Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose

Who this might be right for
Secondary HyperparathyroidismRenal Insufficiency, ChronicParathyroid Hormone+2 more
Abbott 100
Post-approval studies (Phase 4)Study completedNCT03123406
What this trial is testing

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT

Who this might be right for
Hyperparathyroidism; Secondary, Renal
Kyowa Kirin China Pharmaceutical Co., Ltd. 750
Testing effectiveness (Phase 2)Study completedNCT00261950
What this trial is testing

Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease

Who this might be right for
Secondary Hyperparathyroidism
Amgen 110
Post-approval studies (Phase 4)Study completedNCT01100723
What this trial is testing

Trial to Optimize Mineral Outcomes in Dialysis Patients

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
University of Colorado, Denver 92
Not applicableUnknownNCT02464072
What this trial is testing

Subtotal Parathyroidectomy or Total Parathyroidectomy With Autograft in Chronic Kidney Disease Patients Under Dialysis

Who this might be right for
Hyperparathyroidism, Secondary
University of Sao Paulo General Hospital 133
Post-approval studies (Phase 4)Study completedNCT01939977
What this trial is testing

Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.

Who this might be right for
Secondary Hyperparathyroidism Due to Renal Causes
Fundación Senefro 148
Large-scale testing (Phase 3)Study completedNCT01785875
What this trial is testing

Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 891
Testing effectiveness (Phase 2)Study completedNCT02216656
What this trial is testing

Phase 2 Study of KHK7580

Who this might be right for
Secondary Hyperparathyroidism
Kyowa Kirin Co., Ltd. 201
Post-approval studies (Phase 4)Study completedNCT03588884
What this trial is testing

Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency

Who this might be right for
Secondary Hyperparathyroidism Due to Renal CausesVitamin D InsufficiencyCKD Stage 3+1 more
OPKO Health, Inc. 69
Testing effectiveness (Phase 2)Study completedNCT01935856
What this trial is testing

Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

Who this might be right for
Hyperparathyroidism
Kyowa Kirin Co., Ltd. 20
Not applicableStudy completedNCT02523209
What this trial is testing

Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation

Who this might be right for
Chronic Kidney DiseasesHyperparathyroidism, Secondary
Centre Hospitalier Universitaire de Saint Etienne 102
Not applicableStudy completedNCT04637360
What this trial is testing

Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment

Who this might be right for
Hyperparathyroidism; Secondary, Renal
Min-Sheng General Hospital 40
Post-approval studies (Phase 4)Study completedNCT01447368
What this trial is testing

Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients

Who this might be right for
Kidney FailureSecondary HyperparathyroidismVascular Diseases
The University of Hong Kong 67
Not applicableUnknownNCT02332135
What this trial is testing

The Efficacy and Safety of Microwave Ablation for Mild-to-moderate Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

Who this might be right for
Secondary HyperparathyroidismMaintenance Hemodialysis
Wenhu Liu 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06288451
What this trial is testing

DePTH: De-emphasize PTH

Who this might be right for
Kidney Failure, ChronicChronic Kidney Disease-Mineral and Bone Disorder
University of Washington 90
Not applicableLooking for participantsNCT07312981
What this trial is testing

The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations

Who this might be right for
CKDRenal Insufficiency ChronicCKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder+1 more
University of Copenhagen 50
Not applicableLooking for participantsNCT07193056
What this trial is testing

The CPH-MBD Cohort

Who this might be right for
Chronic Kidney Disease Mineral and Bone DisorderChronic Kidney Disease (CKD)Bone Markers
Herlev Hospital 1,000
Testing effectiveness (Phase 2)UnknownNCT06398002
What this trial is testing

The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD

Who this might be right for
Secondary HyperparathyroidismEnd-stage Kidney Disease
Iain Bressendorff 48
Testing effectiveness (Phase 2)Ended earlyNCT01576146
What this trial is testing

Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism
KAI Pharmaceuticals 30
Next Page